Nurix Therapeutics
Price & Volume
Stats
See more52W Range | $11.67-$28.23 |
Market Cap | $2.9B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $701.9M |
Revenue Growth (YoY) | 8,426.3% |
Gross Profit (12 Mos) | $367.8M |
Diluted EPS | $2.43 |
News
See moreYahoo Finance • 18 hours ago
Nurix Therapeutics Announces Sanofi’s Decision to Discontinue Development of STAT6 Degrader SAR448272
Yahoo Finance • 13 days ago
What Nurix Therapeutics Stock's Profit Turnaround Means For Shareholders
Yahoo Finance • 16 days ago
Cathie Wood's weekly recap: adds to CoreWeave, Meta, Recursion; cuts Personalis, Toast
Yahoo Finance • 23 days ago
Nurix Therapeutics falls 2% following Q3 earnings as operating expenses up
About
CEO | Dr. Arthur T. Sands M.D., Ph.D. |
Address | 1600 Sierra Point Parkway, Brisbane, CA, United States, 94005 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 317 |